NovoBiome Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$700K
- Investors
-
3
NovoBiome General Information
Description
Developer of a gut-on-chip from human stem cells, limiting animal studies intended to evaluate oral compounds with more reliable and less costly results than animal experiments. The company focuses on the critical nexus of the liver, intestinal diseases like nonalcoholic steatohepatitis, and the gut microbiome with the development of live biotherapeutics, a novel and emerging class of drugs containing living microorganisms, enabling healthcare providers to increase the effectiveness of therapies and the ratio of responding patients.
Contact Information
Website
www.novobiome.euCorporate Office
- 5 Impasse de la Chapelle
- 33360 Latresne
- France
Corporate Office
- 5 Impasse de la Chapelle
- 33360 Latresne
- France
NovoBiome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 18-Mar-2026 | $700K | Completed | Startup | ||
| 2. Early Stage VC (Series A) | 18-May-2021 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
NovoBiome Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
NovoBiome Comparisons
Industry
Financing
Details
NovoBiome Competitors (6)
One of NovoBiome’s 6 competitors is HUB Organoids, a Formerly Accelerator/Incubator backed company based in Utrecht, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HUB Organoids | Formerly Accelerator/Incubator backed | Utrecht, Netherlands | ||||
| MRM Health | Venture Capital-Backed | Ghent, Belgium | ||||
| InSphero | Private Equity-Backed | Schlieren, Switzerland | ||||
| Emulate | Venture Capital-Backed | Boston, MA | ||||
| TissUse | Accelerator/Incubator Backed | Berlin, Germany |
NovoBiome Signals
NovoBiome Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bernard Magrey Start-Up Win | Accelerator/Incubator | |||
| Eure Kare | VC-Backed Company | Minority | ||
| Unitec (Accelerator/Incubator) | Accelerator/Incubator |
NovoBiome FAQs
-
When was NovoBiome founded?
NovoBiome was founded in 2020.
-
Where is NovoBiome headquartered?
NovoBiome is headquartered in Latresne, France.
-
What is the size of NovoBiome?
NovoBiome has 6 total employees.
-
What industry is NovoBiome in?
NovoBiome’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is NovoBiome a private or public company?
NovoBiome is a Private company.
-
What is NovoBiome’s current revenue?
The current revenue for NovoBiome is .
-
How much funding has NovoBiome raised over time?
NovoBiome has raised $2.15M.
-
Who are NovoBiome’s investors?
Bernard Magrey Start-Up Win, Eure Kare, and Unitec (Accelerator/Incubator) have invested in NovoBiome.
-
Who are NovoBiome’s competitors?
HUB Organoids, MRM Health, InSphero, Emulate, and TissUse are some of the 6 competitors of NovoBiome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process